In 99% of cases, penny stocks are absolute garbage and it’s safe to say that you shouldn’t buy them, including the ideas on this list. Although internet gurus purport to have developed some system that can pinpoint companies with strong upside potential, it’s lies on top of utter nonsense. Look, if the gurus really did have such a system, why would they be selling their secret?
It’s because gurus have absolutely no idea what the [blank] they are talking about that they feel compelled to sell you their best ideas for penny stocks to buy. But if they actually knew what they were talking about, they would just make as much money as they desire off their system. Remember, when it comes to con artists, they get rich off the book sales, not the information provided in them.
And that’s because there is no information – just a bunch of ideas that maybe, just maybe, might do well in the future. More often than not, you just end up losing money on penny stocks.
Still, I know how human nature works. So, if you want some ideas for penny stocks under a dime, here they are.
|FGPHF||First Graphene Limited||$0.0950|
|BRLL||Barrel Energy, Inc.||$0.0389|
|CSOC||Caduceus Software Systems Corp.||$0.0330|
|MJNA||Medical Marijuana, Inc.||$0.0152|
|WHSI||Wearable Health Solutions, Inc.||$0.0198|
|MJWL||Majic Wheels Corp.||$0.0125|
|CBDD||CBD of Denver Inc.||$0.0074|
|QEBR||Virtual Medical International, Inc.||$0.0095|
Penny Stocks: First Graphene Limited (FGPHF)
For full disclosure, I own shares of First Graphene (OTCMKTS:FGPHF) so please don’t add this to your list of penny stocks to consider merely on my mentioning of it. To be quite blunt, I’ve lost my tens of dollars speculating on FGPHF, which is unfortunate. Among the speculative over-the-counter ideas out there, First Graphene is among the most credible.
Focused on the goal of commercializing graphene – the strongest material known to man – if successful, this company offers myriad industrial applications, ranging from concrete protection and resilience, enhanced fireproofing products and ultra-high-mileage electric vehicle batteries, among several other exciting potential uses.
The problem is, Wall Street doesn’t share this bullish opinion. It just goes to show you that even with a scientific, evidence-based thesis, penny stocks can and often do go bad.
Barrel Energy (BRLL)
Speaking of EVs, the electrification of transportation has always been a popular topic because of the environmental implications. But with Russia’s invasion of Ukraine, policymakers across the world are scrambling for renewable energy solutions, of which EVs play an indirect though critical role. On paper, this backdrop favors Barrel Energy (OTCMKTS:BRLL).
Conducting exploration work for the lithium mining industry, Barrel Energy could drive higher based on popular demand for EV-related companies. However, that’s where rational optimism ends and the speculation begins. Without much financial data to work off of, BRLL is purely a shot in the dark.
I’ll give it this much though. Over the trailing month, BRLL shares have been flying, gaining almost 68%.
Caduceus Software Systems (CSOC)
When you conduct your due diligence with penny stocks, you’ll notice that most companies feature vague descriptions about what they do. In my opinion, that’s the case with Caduceus Software Systems (OTCMKTS:CSOC). It’s billed as a specialist in mergers and acquisitions with a particular emphasis on healthcare-related solutions.
OK. Unfortunately, you’re not going to get a great read on its financials. For one thing, Caduceus’s balance sheet is in deficit. Perhaps not surprisingly, the company posted a net loss of $205,355 in the fourth quarter of 2021. However, it was cash flow positive during this period.
As for market potential, CSOC’s price action resembles a seismograph. In other words, it’s a literal gamble.
Penny Stocks: Medical Marijuana (MJNA)
Medical Marijuana (OTCMKTS:MJNA) develops, sells and distributes hemp oil across a variety of platforms, from tinctures to capsules to edibles such as gummies. It even offers cannabidiol (CBD) products for pets, just in case Fido needs to relax. Part of Medical Marijuana’s charm is that its products help normalize cannabis as an alternative therapeutic.
Fundamentally, it’s possible that should the economy fall into a recession, stress-relieving products will be in high demand (no pun intended). In addition, troubled times tend to cynically bring about vice activities. It stands to reason that legal cannabis demand could enjoy a boon.
Still, illicit cannabis could likewise compete with the legal variant, posing big problems for MJNA and other cannabis-related penny stocks.
Wearable Health Solutions (WHSI)
As its name suggests, Wearable Health Solutions (OTCMKTS:WHSI) specializes in the burgeoning wearable medical device industry. According to Grand View Research, this sector (worldwide) was valued at $21.3 billion in 2021. However, experts project that by 2030, the segment could expand to $196.6 billion, representing a compound annual growth rate of 28.1% between 2022 to the end of the forecasted period.
Specifically for Wearable Health, it focuses on mobile medical alert solutions. Personally, it’s an intriguing concept because of the number of baby boomers that are entering retirement age. Leveraging the power of medical technology, their progeny can keep tabs on them through integrated solutions.
Still, this company generates very little revenue and consistently posts net losses. Therefore, only hardened gamblers of penny stocks need apply.
Generally, it’s not a good idea to buy penny stocks, certainly not ones that cost less than 2 cents a share. However, Cyberlux (OTCMKTS:CYBL) has been on a roll recently, gaining nearly 33% for the June 8 session. Out of the speculative ideas discussed here that I don’t own, CYBL is what I find to be the most attractive.
A tech firm specializing in various solutions for government and defense agencies, such as unmanned aircraft, smart infrastructure and advanced lighting systems, Cyberlux features an actual track record, which is far more than you can say about most literal penny stocks. As well, the company is delivering on the financial front, increasing revenue by 12% on a month-over-month basis and exceeding its April 2022 revenue plan.
Still, it is one of the penny stocks so supreme caution is necessary.
Penny Stocks: AiAdvertising (AIAD)
Although digitalization has made much of analog advertising obsolete, that doesn’t mean that advertising as an industry has become irrelevant. Far from it, with businesses being more competitive than ever, enterprises need an edge to stay on top of the game. That’s where AiAdvertising (OTCMKTS:AIAD) comes into the frame.
Leveraging artificial intelligence and other advanced protocols, AiAdvertising’s main goal is to make marketing smart. Through targeted efforts and data-driven initiatives, the company eliminates guesswork and helps drive up return on investment for its clients.
Clearly, AIAD has done great work for itself, with its share price soaring over 71% in the training five days since the close of the June 8 session. Still, being one of the literal penny stocks, it’s best to be extremely conservative.
Majic Wheels (MJWL)
If you thought literal penny stocks were dangerous, how about those priced in fractions of a penny? At time of writing, that’s exactly the case with Majic Wheels (OTCMKTS:MJWL), and I can’t say without good reason. Featuring a vague description of what it does, from what I can understand, Majic is a holding company that seeks to acquire disruptive firms.
Now, part of the allure of MJWL stock is its ties with blockchain-related enterprises. Majic has done some business in this arena and with the rise of cryptocurrencies in 2021, it’s a natural place to gin up interest. So, if MJWL is to bring smiles to stakeholders’ faces, it’s got to hope that cryptos find their mojo again.
Even if they do, that won’t take away from the extremely speculative nature of Majic Wheels. Trade carefully.
CBD of Denver (CBDD)
Another cannabis play among the ranks of penny stocks, CBD of Denver (OTCMKTS:CBDD) might be a little too close to its subject matter considering its strange name. As far as I can tell, it has no connection to Denver unless it’s referring to the community in Nova Scotia. Anyways, CBD of Denver wants to establish itself as the market leader for the European cannabis space.
In addition, the company also has expansion strategies targeting Asia, which would be remarkable given the region’s incredibly conservative views of botanical solutions. Fundamentally, CBD of Denver has upside potential, particularly as societal and economic pressure points converge to cause massive stress. Cannabis products help take the edge off, or so I’ve been told.
Still, all cannabis firms face challenges these days so I would be super careful with CBDD.
Penny Stocks: Virtual Medical International (QEBR)
I’m going to be painfully honest. I stuck Virtual Medical International (OTCMKTS:QEBR) on here because I needed something to finish the list of penny stocks that are priced under a dime. At a few mini ticks below a penny, QEBR qualifies. Whether it’s even worth your time – well, probably not.
I’ll say this much. Virtual Medical is interesting in that the company aims to provide medical educational resources online. From what I can gather, it’s the Wikipedia for health-related inquiries. Still, I don’t want to be a smart aleck but that’s sort of what Wikipedia is for. You also got to figure that there would be serious competition for this kind of business.
But whatever, if you have some under-the-sofa change that you want to burn, QEBR is your “opportunity.”
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
On the date of publication, Josh Enomoto held a LONG position in FGPHF. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.